Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities1
Barry J. Maron, MD, FACCa,
Robert Mathenge, MDa,
Susan A. Casey, RNa,
Liviu C. Poliac, MDa and
Terrence F. Longe, MDa
a Cardiovascular Research Division, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA

View larger version (21K):
[in a new window]
|
Figure 1 Flow diagram summarizing the echocardiographic findings and identification of hypertrophic cardiomyopathy (HCM) in the overall patient study group from rural, primary medical practice. LVH = left ventricular hypertrophy.
|
|

View larger version (58K):
[in a new window]
|
Figure 2 Age distribution in years at the time of initial hypertrophic cardiomyopathy diagnosis. Those 12 patients without functional limitation when recognized clinically are shown as stippled portions of the bars.
|
|

View larger version (59K):
[in a new window]
|
Figure 3 Extent of left ventricular hypertrophy (assessed by two-dimensional echocardiography) expressed as the number of hypertrophied left ventricular segments in each patient. The present study patients with HCM are compared with a previously reported hospital-based tertiary center HCM population (14).
|
|
|